4//SEC Filing
Haddock Jason 4
Accession 0000899243-20-028422
CIK 0001659352other
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 8:14 PM ET
Size
8.7 KB
Accession
0000899243-20-028422
Insider Transaction Report
Form 4
Haddock Jason
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-08-26+31,981→ 31,981 totalExercise: $19.47Exp: 2030-08-25→ Common Stock (31,981 underlying) - Award
Stock Option (Right to Buy)
2020-10-13+10,000→ 10,000 totalExercise: $15.00Exp: 2030-10-12→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]On October 2, 2020, the Issuer completed a 1-for-7.187 reverse stock split of the Issuer's Common Stock ("Reverse Stock Split"). This amount has been adjusted to give effect to the Reverse Stock Split.
- [F2]This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.
- [F3]25% of this option shall vest and become exercisable on August 26, 2021, with the remainder vesting in 12 equal quarterly installments thereafter.
- [F4]This option shall vest in full upon the earlier to occur of (i) October 13, 2021, and (ii) the next annual meeting of the Issuer's stockholders.
Documents
Issuer
Codiak BioSciences, Inc.
CIK 0001659352
Entity typeother
Related Parties
1- filerCIK 0001680628
Filing Metadata
- Form type
- 4
- Filed
- Oct 14, 8:00 PM ET
- Accepted
- Oct 15, 8:14 PM ET
- Size
- 8.7 KB